Epilepside Yaşam Kalitesi Komorbite ve Mortalite

Record EJ, Bumbut A, Shih S, Merwin S, Kroner B, Gaillard WD, Risk factors, etiologies, and comorbidities in urban pediatric epilepsy , Epilepsy & Behavior 2021; 115 107716

Kerr MP, The İmpact of epilepsy on patients’ lives, Acta Neurol Scand 2012:126,194

Eddy CM, Rickards HE, Cavanna AE, The Cognitive İmpact of Antiepileptik Drugs. Ther Adv Neurol Disord 2011;4:385-407

Hwang S, Ettinger A, So EL, Epilepsy Comorbidities, Continuum Lifelong Learning Neurol 2010, 16(3):86-104

Lafrance WC Jr, Kanner AM, Herman B. Psychiatric comorbities in epilepsy. Int Rev Neurobiol 2008;83:347-383

Dagar A, Falcone T. Psychiatric Comorbidities in Pediatric Epilepsy, Current Psychiatry Reports 2020, 22:77

Brodie MJ, Besag F, Ettinger AB, Mula M, Gobbi G, Comai S, et al. Epilepsy, antiepileptic drugs, and aggression: an evidencebased review. Pharmacol Rev. 2016;68:563–602.

Chen B, Detyniecki K, Choi H, Hirsch L, Katz A, Legge A, et al. Psychiatric and behavioral side effects of anti-epileptic drugs in adolescents and children with epilepsy. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc. 2017;21:441–9.

Farkas V, Steinborn B, Flamini JR, Zhang Y, Yuen N, Borghs S, et al. Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures. Neurology. 2019;93:e1212–26.

Marino S, Vitaliti G,Marino SD, Pavone P, Provvidenti S, Romano C, et al. Pyridoxine add-on treatment for the control of behavioral adverse effects induced by Levetiracetam in children: a case-control prospective study. Ann Pharmacother. 2018;52:645–9.

Seidenberg M, Pulsipher DT, Herman B, Cognitive Progresyon in Epilepsy. Neuropsychol Rev 2007;12(4):445-454.

McDermott S, Mani S, Krishnawami S. A population-based analysis of specific behavior problems associated with childhood seizures. J Epilepsy. 8:110–8.

Davies S, Heyman I, Goodman R. A population survey of mental health problems in children with epilepsy. Dev Med Child Neurol. 2003;45:292–5.

Matson RH, Gidal BE. Fractures, Epilepsy and Epileptic Drugs. Epilepsy Behav 2004;5(Suppl.2):S36-40

Svalheim S, Roste LS, Nakken KO, Tauboll E. Bone Health in Adults with Epilepsy. Acta Neurol Scand Suppl 2011;191:89-95

Elliott JO, Lu B,Shneker B, Charyton C, Moore JL. Comorbidity, health screening, and quality of life among persons with a history of epilepsy. Epilepsy and Behavior 2009:14;125-129

Nancy A et all, Bone Health and Endocrine Comorbitidies in Pediatric Epilepsy. Semin Pediatric Neurology.2017:24;301-309

Aniego EA, Sheth RD: Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol 14:196-200, 2007

Sheth RD: Metabolic concerns associated with antiepileptic medications. Neurology 63:S24-S29, 2004

Farhat G, Yamout B, Mikati MA, et al: Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58:1348-1353, 2002

Opeskin K, Berkovic SF. Risk factors for sudden unexpected death in epilepsy: a controlled prospective study based on coroners cases. Seizure 2003;12(7):456–464.

Langan Y, Nashef L, Sander JW. Case-control study of SUDEP. Neurology 2005;64:1131–1133.

Leestma J, Walczak T, Hughes JR, et al. A prospective study on sudden unexpected death in epilepsy. Ann Neurol 1989;26:195–203.

Britton J, Ghearing G, Benarroch EE, Cascino GD. The ictal bradycardia syndrome: localization and lateralization. Epilepsia 2006;47:737–744.

Record EJ, Bumbut A, Shih S, Merwin S, Kroner B, Gaillard WD, Risk factors, etiologies, and comorbidities in urban pediatric epilepsy , Epilepsy & Behavior 2021; 115 107716

Kerr MP, The İmpact of epilepsy on patients’ lives, Acta Neurol Scand 2012:126,194

Eddy CM, Rickards HE, Cavanna AE, The Cognitive İmpact of Antiepileptik Drugs. Ther Adv Neurol Disord 2011;4:385-407

Hwang S, Ettinger A, So EL, Epilepsy Comorbidities, Continuum Lifelong Learning Neurol 2010, 16(3):86-104

Lafrance WC Jr, Kanner AM, Herman B. Psychiatric comorbities in epilepsy. Int Rev Neurobiol 2008;83:347-383

Dagar A, Falcone T. Psychiatric Comorbidities in Pediatric Epilepsy, Current Psychiatry Reports 2020, 22:77

Brodie MJ, Besag F, Ettinger AB, Mula M, Gobbi G, Comai S, et al. Epilepsy, antiepileptic drugs, and aggression: an evidencebased review. Pharmacol Rev. 2016;68:563–602.

Chen B, Detyniecki K, Choi H, Hirsch L, Katz A, Legge A, et al. Psychiatric and behavioral side effects of anti-epileptic drugs in adolescents and children with epilepsy. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc. 2017;21:441–9.

Farkas V, Steinborn B, Flamini JR, Zhang Y, Yuen N, Borghs S, et al. Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures. Neurology. 2019;93:e1212–26.

Marino S, Vitaliti G,Marino SD, Pavone P, Provvidenti S, Romano C, et al. Pyridoxine add-on treatment for the control of behavioral adverse effects induced by Levetiracetam in children: a case-control prospective study. Ann Pharmacother. 2018;52:645–9.

Seidenberg M, Pulsipher DT, Herman B, Cognitive Progresyon in Epilepsy. Neuropsychol Rev 2007;12(4):445-454.

McDermott S, Mani S, Krishnawami S. A population-based analysis of specific behavior problems associated with childhood seizures. J Epilepsy. 8:110–8.

Davies S, Heyman I, Goodman R. A population survey of mental health problems in children with epilepsy. Dev Med Child Neurol. 2003;45:292–5.

Matson RH, Gidal BE. Fractures, Epilepsy and Epileptic Drugs. Epilepsy Behav 2004;5(Suppl.2):S36-40

Svalheim S, Roste LS, Nakken KO, Tauboll E. Bone Health in Adults with Epilepsy. Acta Neurol Scand Suppl 2011;191:89-95

Elliott JO, Lu B,Shneker B, Charyton C, Moore JL. Comorbidity, health screening, and quality of life among persons with a history of epilepsy. Epilepsy and Behavior 2009:14;125-129

Nancy A et all, Bone Health and Endocrine Comorbitidies in Pediatric Epilepsy. Semin Pediatric Neurology.2017:24;301-309

Aniego EA, Sheth RD: Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol 14:196-200, 2007

Sheth RD: Metabolic concerns associated with antiepileptic medications. Neurology 63:S24-S29, 2004

Farhat G, Yamout B, Mikati MA, et al: Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 58:1348-1353, 2002

Opeskin K, Berkovic SF. Risk factors for sudden unexpected death in epilepsy: a controlled prospective study based on coroners cases. Seizure 2003;12(7):456–464.

Langan Y, Nashef L, Sander JW. Case-control study of SUDEP. Neurology 2005;64:1131–1133.

Leestma J, Walczak T, Hughes JR, et al. A prospective study on sudden unexpected death in epilepsy. Ann Neurol 1989;26:195–203.

Britton J, Ghearing G, Benarroch EE, Cascino GD. The ictal bradycardia syndrome: localization and lateralization. Epilepsia 2006;47:737–744.